HK Short Interest: Wuxi Biologics, Techtronic, Tencent, XPeng
We highlight weekly short interests changes in Wuxi Biologics, Techtronic, Tencent, XPeng based on the latest HK SFC Short Aggregate report.
273 Views
A Mid-Year Review of Our “Buy the Worst” Strategy 2022: In Tandem with the HSI
While "Buy the Worst" strategy only performed in line with the HSI YTD, there is potential for the portfolio to catch up in 2H22. Meanwhile, "Buy...
405 Views
HK Short Interest: HSBC, Techtronic, SHK Properties, Kuaishou
We highlight week on week short interest increases for HSBC, Techtronic, SHK Properties, Kuaishou based on the latest HK SFC short aggregate report.
202 Views
China: EM Active Fund Positioning Update. BABA Drives Allocations Lower
China allocations fall to 2-year low, driven by widespread closures in Alibaba Group, New Oriental Education, China Mobile and CNOOC Ltd.
267 Views
“Buy the Worst” Strategy into Year 3: What's on for 2022 to Beat the HSI?
Our "Buy the Worst" strategy outperformed HSI by a massive 26.1pp YTD. For 2022, new names are Haidilao, Ali Health, Alibaba, Sands China and...
659 Views